Anti-tuberculosis Drug Resistance and HIV Co-infection in Phnom Penh, Cambodia
Overview
Authors
Affiliations
The objective of this study was to observe the prevalence of drug resistance in Mycobacterium tuberculosis isolates in HIV associated tuberculosis co-infected patients in Phnom Penh City. The isolates of M. tuberculosis were collected during active laboratory-based surveillance. Of the 98 isolates studied, M. tuberculosis resistance to isoniazid was seen in 23.5%, resistance to rifampicin was seen in 16.3% and multidrug-resistance (MDR-TB) was seen in 5.1%. Our findings reveal an alarmingly high level of resistance to isoniazid and rifampicin, and confirms the need for drug susceptibility testing to guide treatment in patients with culture positive tuberculosis.
Sam S, Shapiro A, Sok T, Khann S, So R, Khem S BMJ Open Respir Res. 2018; 5(1):e000256.
PMID: 29955361 PMC: 6018896. DOI: 10.1136/bmjresp-2017-000256.
Walls G, Bulifon S, Breysse S, Daneth T, Bonnet M, Hurtado N Glob Health Action. 2015; 8:25964.
PMID: 25623609 PMC: 4306750. DOI: 10.3402/gha.v8.25964.
Goyet S, Vlieghe E, Kumar V, Newell S, Moore C, Bousfield R PLoS One. 2014; 9(3):e89637.
PMID: 24626053 PMC: 3953073. DOI: 10.1371/journal.pone.0089637.
Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria.
Otu A, Umoh V, Habib A, Ameh S, Lawson L, Ansa V Pulm Med. 2013; 2013:235190.
PMID: 24078872 PMC: 3781831. DOI: 10.1155/2013/235190.
Linking surveillance with action against drug-resistant tuberculosis.
Cohen T, Manjourides J, Hedt-Gauthier B Am J Respir Crit Care Med. 2012; 186(5):399-401.
PMID: 22592806 PMC: 3443807. DOI: 10.1164/rccm.201203-0394PP.